In Vivo transdermal delivery of diclofenac by ion-exchange iontophoresis with geraniol

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 4, 2009, Pages 684-687

  Kigasawa, Kaoru ^a,b   Kajimoto, Kazuaki ^a   Watanabe, Misuzu ^a   Kanamura, Kiyoshi ^b   Saito, Akiyoshi ^b   Kogure, Kentaro ^c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TTI Ellebeau Inc   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Anti inflammatory drug; Diclofenac sodium; Geraniol; Iontophoresis; Transdermal drug delivery

Indexed keywords

DICLOFENAC; GERANIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANION EXCHANGE; ANION TRANSPORT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG POTENTIATION; DRUG SAFETY; IN VIVO STUDY; INJECTION SITE IRRITATION; IONTOPHORESIS; MALE; NONHUMAN; PAW EDEMA; RAT; SKIN PENETRATION; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; DICLOFENAC; DRUG SYNERGISM; EDEMA; ION EXCHANGE; IONTOPHORESIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; STIMULATION, CHEMICAL; TERPENES;

EID: 65249171439     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.684     Document Type: Article

References (20)

1. Tyle P., Pharm. Res., 3, 318-326 (1986).
2. Varghese E., Khar R. K., J. Controlled Release, 38, 21-27 (1996).
3. Prausnitz M. R., Adv. Drug Deliv. Rev., 18, 395-425 (1996).
4. Liu J. C., Sun Y., Siddiqui O., Chien Y. W., Shi W. M., Li J., Int. J. Pharm., 44, 197-204 (1988).
5. Costello C. T., Jeske A. H., Phys. Ther., 75, 554-563 (1995).
6. Behl C. R., Kumar S., Malick A. W., Delterzo S., Higuchi W. I., Nash R. A., J. Pharm. Sci., 78, 355-360 (1989).
7. Siddiqui O., Roberts M. S., Polack A. E., J. Pharm. Pharmacol., 37, 732-735 (1985).
8. Phipps J. B., Padmanabhan R. V., Lattin g. A., J. Pharm. Sci., 78, 365-369 (1989).
9. Sanderson J. E., Deriel S., Dixon R., J. Pharm. Sci., 78, 361-364 (1989).
10. Numajiri S., Sakurai H., Sugibayashi K., Morimoto Y., Omiya H., Takenaka H., Akiyama N., J. Pharm. Pharmacol., 45, 610-613 (1993).
11. Davies N. M., Anderson K. E., Clin. Pharmacokinet., 33, 184-213 (1997).
12. Marsh C. C., Schuna A. A., Sundstrom W. R., Pharmacotherapy, 6, 10-25 (1986).
13. Burnette R. R., Ongpipattanakul B., J. Pharm. Sci., 76, 765-773 (1987).
14. Pillai O., Panchagnula R., J. Controlled Release, 88, 287-296 (2003).
15. Bligh E. g., Dyer W. J., Can. J. Biochem. Physiol., 37, 911-917 (1959).
16. Fang J. Y., Wang R. J., Huang Y. B., Wu P. C., Tsai Y. H., Biol. Pharm. Bull., 24, 390-394 (2001).
17. Tashiro Y., Shichibe S., Kato Y., Hayakawa E., Itoh K., Biol. Pharm. Bull., 24, 278-283 (2001).
18. Arellano A., Santoyo S., Martin C., Ygartua P., Int. J. Pharm., 130, 141-145 (1996).
19. Nokhodchi A., Sharabiani K., Rashidi M. R., Ghafourian T., Int. J. Pharm., 335, 97-105 (2007).
20. Williams A. C., Barry B. W., Pharm. Res., 8, 17-24 (1991).